Supportive Medications for Acute Ischemic Stroke with Hemiplegia
For an adult patient with acute parieto-occipital ischemic stroke and hemiplegia, you should immediately initiate aspirin 160-325 mg daily (after excluding hemorrhage and completing dysphagia screening), subcutaneous anticoagulation for DVT prophylaxis, statin therapy, antipyretics for fever >37.5°C, and insulin for glucose >140-180 mg/dL. 1, 2, 3, 4
Antiplatelet Therapy
Aspirin 160-325 mg should be administered within 24-48 hours of stroke onset to reduce mortality and morbidity 5, 1, 2. This represents a Grade A recommendation with the strongest evidence base. The primary benefit comes from preventing early recurrent stroke rather than limiting the initial neurological damage 1.
Critical timing considerations:
- If the patient received tPA, delay aspirin for 24 hours until post-thrombolysis imaging excludes hemorrhage 2, 3
- If the patient cannot swallow, use rectal aspirin 325 mg daily or enteral tube administration of 80 mg daily 2, 3
- A single loading dose of 160 mg is recommended initially 6
DVT Prophylaxis
Subcutaneous unfractionated heparin, low molecular weight heparins, or heparinoids should be initiated for deep venous thrombosis prophylaxis in this immobilized patient with hemiplegia 5, 3. This is a Grade A recommendation. The benefit in reducing DVT risk outweighs the small increase in hemorrhagic complications 5.
Important caveat: These agents are recommended specifically for DVT prophylaxis, NOT for reducing stroke mortality, morbidity, or preventing early recurrent stroke—where they have shown no benefit or potential harm 5.
Glucose Management
Maintain blood glucose between 140-180 mg/dL using insulin therapy 1, 4. Hyperglycemia >140 mg/dL during the first 24 hours after stroke is associated with worse outcomes 4. Avoid hypoglycemia <60 mg/dL (3.3 mmol/L), which carries Class I evidence for harm 3, 4.
Temperature Control
Treat fever >37.5°C with antipyretic medications 1, 3, 4. Hyperthermia is associated with worse outcomes and increased mortality 4. This is a Class I, Level of Evidence C recommendation 1.
Blood Pressure Management
Exercise caution with blood pressure lowering in acute stroke. Unless systolic BP >220 mmHg or diastolic >120 mmHg, avoid aggressive treatment 1. Many patients experience spontaneous BP decline in the first 24 hours. If treatment is necessary, lower BP by approximately 15% during the first 24 hours 1.
Lipid Management
Initiate high-dose statin therapy for secondary prevention, particularly if intracranial atherosclerotic stenosis is identified 6. This represents a strong recommendation across multiple guidelines.
Additional Supportive Measures
Hydration: Maintain euvolemia with isotonic normal saline. Avoid volume expanders for hemodilution (Class III evidence) 3.
Nutrition: For dysphagia, prefer nasoenteric tube feeding over PEG tube for the first 2-3 weeks 3.
Cardiac monitoring: Screen for atrial fibrillation and serious arrhythmias (Class I, Level B) 1.
Oxygen: Only supplement if saturation <92% 1, 3.
What NOT to Do
- Do not use urgent full-dose anticoagulation (IV heparin, high-dose LMWH) to treat the stroke itself—no benefit demonstrated and increased bleeding risk 5
- Do not combine aspirin with clopidogrel acutely unless this is a minor stroke (NIHSS ≤3) presenting within 24 hours 1, 6
- Do not use neuroprotective agents—no proven benefit 7
- Do not routinely use indwelling urinary catheters—infection risk outweighs benefits 3
Rehabilitation Considerations
Early mobilization within 24 hours is safe and feasible for neurologically and hemodynamically stable patients 3, 8. This patient with hemiplegia requires formal rehabilitation assessment, positioning to prevent shoulder subluxation and contractures, and daily stretching of hemiplegic limbs 8.